Is Rocket Pharmaceuticals Inc (NASDAQ: RCKT) Back In The Buying Zone?
Currently, there are 106.45M common shares owned by the public and among those 98.97M shares have been available to trade. The company’s stock has a 5-day price change of -28.89% and -50.55% over the past three months. RCKT shares are trading -53.78% year to date (YTD), with the 12-month market performance down to -78.43% lower. […]